Virgilio, I’d rather people ask the questions I haven’t thought of yet. I didn’t even notice that the title of Dr. Bosch’s talk was clinical immunotherapies, not immunotherapy, until I was more than half way through my answer to you. I think many people on this board think we need to analyze every move management makes in terms of what they’re trying to hint to us investors, when, in fact, sometimes they’re just trying to do their job, which includes getting the word out to doctors about their products.
News 
Market Data 
Discover 
